News & Updates
Filter by Specialty:

Adjuvant nivolumab delivers in muscle-invasive bladder cancer
09 Mar 2025
byJairia Dela Cruz
Adjuvant nivolumab appears to improve survival outcomes in patients with muscle-invasive bladder cancer (MIBC) who have undergone radical surgery, regardless of prior exposure to neoadjuvant chemotherapy, according to additional data from the phase III CheckMate 274 trial.